Considering the possible class effect, if TNF inhibitor-induced vasculitis occurs, an alternative class agent may be indicated; careful monitoring is needed since cases of vasculitis recurrence after a change in the anti-TNF agent have been reported [26]. This evidence concerns the gene TNF and vasculitis.